EBF is an organisation comprised of bioanalytical scientists working within the pharmaceutical industry R&D. The scope of EBF is on bioanalysis of small and large molecules with 'bioanalysis' being defined as: - quantification of drug and metabolites in body fluids and tissues - quantification of PD and safety biomarkers amenable to conventional bioanalytical techniques - bioanalytical characterization of NBEs We discuss on regulatory issues and aspects (new guidelines, interpretation of existing guidelines) and present our joint opinion towards regulatory bodies and our peers. Further, we share common practices - outside the IP area - on procedures, science, LIMS, validation, quality (GLP), etc and we discuss new developments in industry.